Medically reviewed by Daniel More, MD Medications that target inflammation, such as immunotherapy and steroids, treat allergic asthma, a common type of asthma. Identifying triggers and avoiding ...

The FDA has just handed an advantage to GlaxoSmithKline’s triple therapy for chronic obstructive pulmonary disease (COPD) by rejecting AstraZeneca’s PT010, a close competitor. AZ has confirmed ...

Objective: To review the basis for the estimated comparative daily dosages of inhaled corticosteroids for children and adults that are presented in the National Heart, Lung, and Blood Institute's ...

Examples of acceptable treatments: Acceptably treated patients with less severe asthma received a mean daily dose of inhaled β agonists equivalent to less than 1–2 inhalations a day in combination ...

Correspondence to Dr Sharon Conroy, Division of Medical Sciences & Graduate Entry Medicine, School of Medicine, University of Nottingham, Royal Derby Hospital Centre, Uttoxeter Road, Derby DE22 3DT, ...

She was diagnosed with gastrointestinal graft vs host disease (GVHD, stage 3), with no skin rash or liver involvement. She received immunosuppressive therapy (ie, methylprednisolone and beclomethasone ...

Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive pulmonary disease (COPD). Aside from the fact that they are ineffective for COPD, these inhalers can pose risks ...